FDA warns websites marketing unapproved opioids

June 11, 2018

(HealthDay)—Nine online networks, operating 53 websites, have been warned that they must stop illegally marketing potentially dangerous, unapproved, and misbranded versions of opioid medications, according to the U.S. Food and Drug Administration.

As part of the effort to crack down on sales of illegal narcotics over the internet, a summit will be hosted with stakeholders to find new ways to collaborate and address these issues. In addition, the FDA will be taking action against companies whose websites break the law. Warning letters were sent to nine online networks; these will be followed by additional steps to prevent the flow of illegal, unapproved opioids.

Patients who buy from illegal online pharmacies may be putting their health at risk as these products could be counterfeit, contaminated, expired, or unsafe. In violation of the Federal Food, Drug, and Cosmetic Act, the websites offer opioids for sale that are misbranded and new drugs that are unapproved. The companies have been asked to respond within 10 working days, and are directed to inform the agency of specific actions taken.

"This illegal online marketing of unapproved opioids is contributing to the nation's crisis," FDA Commissioner Scott Gottlieb, M.D., said in a statement. "The new warning letters are part of a comprehensive campaign to target of unapproved opioids."

Explore further: FDA seizes counterfeit drugs, devices sold online

More information: More Information

Related Stories

FDA seizes counterfeit drugs, devices sold online

June 19, 2015
(HealthDay)—The U.S. Food and Drug Administration, along with international partners, moved this week against more than 1,050 websites that sell potentially dangerous counterfeit medicines and medical devices, the agency ...

FDA targets clinics offering unapproved stem cell therapies

May 11, 2018
(HealthDay)—The U.S. Food and Drug Administration has launched legal action to stop two stem cell clinics from providing unapproved treatments that have caused serious, long-term harm to some patients.

Multinational companies continue to produce unregulated antibiotics in India

February 5, 2018
Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University.

White House launches anti-opioid ad campaign aimed at youth

June 7, 2018
The White House launched a series of new advertisements Thursday aimed at warning young people about the dangers of opioids, taking another step in the effort to turn the tide against the deadly epidemic.

Canadian pharmacy fined $34 million for illegal imports

April 13, 2018
An online pharmacy that bills itself as Canada's largest was fined $34 million Friday for importing counterfeit cancer drugs and other unapproved pharmaceuticals into the United States, a sentence that one advocacy group ...

US cracks down on illegal diabetes remedies

July 23, 2013
(AP)—The Food and Drug Administration is cracking down on more than a dozen U.S. and foreign companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription drugs sold online ...

Recommended for you

Medicating distress: Risky sedative prescriptions for older adults vary widely

October 18, 2018
Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

Medical management of opioid-induced constipation differs from other forms of condition

October 17, 2018
Traditional laxatives are recommended as first-line agents to treat patients with a confirmed diagnosis of opioid-induced constipation (OIC), according to a new guideline from the American Gastroenterological Association ...

Research assesses geographic distribution of new antibiotics following market introduction

October 16, 2018
There is a growing need for new antibiotics to help combat the looming threat of antimicrobial resistance. According to a new study conducted by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) with ...

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.